DERENZINI, ENRICO

DERENZINI, ENRICO  

Dipartimento di Scienze della Salute  

Mostra records
Risultati 1 - 20 di 99 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Germline BRCA pathogenic variants and hematologic adverse events in patients with ovarian carcinoma receiving PARP inhibitors: a retrospective cohort study 2025 Valenza CTrapani DKatrini JBoldrini LBoscolo Bielo LGuidi LPellizzari GDerenzini ECurigliano G + Article (author) -
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular Lymphoma 2025 Davini AMelle FVanazzi ACastelli MTarella CDerenzini E + Article (author) -
Germline BRCA pathogenic variants in patients with ovarian cancer and post-poly (ADP-ribose) polymerase inhibitor myeloid neoplasms 2024 Trapani, D.Katrini, J.Boldrini, L.Boscolo Bielo, L.Guidi, L.Pellizzari, G.Derenzini, E.Curigliano, G. + Article (author) -
Venetoclax Plus Intensified Chemoimmunotherapy as a Bridge to Allogeneic Stem Cell Transplantation in Richter Syndrome: Report of Two Cases 2024 Derenzini EVanazzi AMelle FBonello LTarella C + Article (author) -
Hairy cell leukemia with an atypical extranodal presentation: A clinicopathological analysis of four cases 2024 Sangiorgio, ValentinaDerenzini, EnricoVanazzi, Anna + Article (author) -
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies 2024 Vanazzi, AnnaMarasco, VincenzoLeotta, SalvatoreDerenzini, EnricoRambaldi, AlessandroTarella, Corrado + Article (author) -
Identification of Novel Potential Predisposing Variants in Familial Acute Myeloid Leukemia 2024 Ronchini, ChiaraFontanini, MartinaAmato, VivianaGregato, GiulianaDerenzini, EnricoTarella, CorradoAlcalay, Myriam + Article (author) -
[¹⁸ F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma [$\less$sup$\greater$18$\less$/sup$\greater$F]-{FDG} {PET} radiomic model as prognostic biomarker in diffuse large B-cell lymphoma] 2023 Francesca BottaEnrico DerenziniTommaso RadiceSaveria MazzaraCorrado TarellaSara RaimondiFrancesco Ceci + Article (author) -
Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study 2023 Derenzini, Enrico + Article (author) -
Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL 2023 Mazzara, SaveriaBotta, FrancescaFiori, StefanoVanazzi, AnnaRadice, TommasoRaimondi, SaraJereczek-Fossa, Barbara AlicjaTarella, CorradoCeci, FrancescoDerenzini, Enrico + Article (author) -
Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13) 2023 Derenzini, Enrico + Article (author) -
SARS-CoV-2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID-19 cohort 2023 Derenzini, EnricoFederici, Augusto BramanteGuidetti, AnnaCorradini, PaoloPassamonti, Francesco + Article (author) -
BIA-ALCL in patients with genetic predisposition for breast cancer: our experience and a review of the literature 2023 Carbonaro, RiccardoMazzocconi, LucaDerenzini, EnricoVeronesi, Paolo + Article (author) -
Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients 2022 Derenzini, EnricoTarella, Corrado + Article (author) -
Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma 2022 Corradini, PaoloDerenzini, EnricoGuidetti, AnnaPassamonti, FrancescoRambaldi, AlessandroTarella, Corrado + Article (author) -
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era 2022 Mussetti, AlbertoDerenzini, Enrico + Article (author) -
An integrated prognostic model for diffuse large B-cell lymphoma treated with immunochemotherapy 2022 Derenzini, Enrico + Article (author) -
The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade 2022 Mazzara, SaveriaFabbri, MarcoFiori, StefanoLorenzini, DanieleDerenzini, EnricoVanazzi, AnnaTarella, Corrado + Article (author) -
NR1H3 (LXRα) is associated with pro-inflammatory macrophages, predicts survival and suggests potential therapeutic rationales in diffuse large b-cell lymphoma 2022 Mazzara, SaveriaFiori, StefanoDerenzini, Enrico + Article (author) -
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamics 2022 Guidetti, AnnaBramanti, StefaniaMorello, LuciaDerenzini, EnricoCorradini, Paolo + Article (author) -